Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication

Tumori

Volumn 88, Issue 3, 2002, Pages 215-223

  Heinig, Anke ^a   Lampe, Dieter ^a   Kölbl, Heinz ^a   Beck, Rainer ^a   Heywang Köbrunner, Sylvia H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antiestrogens; Breast; Enhancement; Magnetic resonance imaging

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE;

EID: 0036347214     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800307     Document Type: Article

References (19)

1. MR characterisation of suspicious breast lesions with a gadolinium-enhanced Turbo FLASH subtraction technique
2. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis
3. Multi-feature analysis of Gd-enhanced MR images of breast lesions
4. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
5. Characterisation of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI
6. International investigation of breast MRI: Results of a multi-centre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions
7. In situ and minimally invasive breast cancer: Morphologic and kinetic features on contrast-enhanced MRI
8. Contrast-enhancement of proliferative dysplasia in MRI of the breast due to the menstruation cycle
9. Effect of age and menstrual cycle on mammography and MR mammography
10. Healthy pre-menopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency
11. Clinical safety of gadopentetate dimeglumine
12. Cell kinetics of the human mammary lobule during the proliferative and secretory phase of the menstrual cycle
13. Tamoxifen and the gynaecologist
14. Proliferation of breast epithelial cells in healthy women during menstrual cycle
15. Endocrine pharmacology of anti-estrogens as anti-tumour agents
16. Growth factor regulation by tamoxifen is demonstrated in patients with breast cancer
17. Down regulation of transforming growth factor alpha by tamoxifen in human breast cancer
18. Biologic activity of tamoxifen at low doses in healthy women